Our Transdermal Drug Delivery System provides novel approaches and devices to enable successful drug delivery as a form of transdermal patch. Our focused strategy is to use science-based innovation to support patients better compliance in growing areas of healthcare. We invest in the most promising frontier of transdermal drug penetration and diverse patch structure design technology. In addition, we support the most exciting innovations in the business of drug release control technology, and the manufacturing processes. Under strict processes and quality controls at the KGMP production facilities, we produce and supply products to domestics and international partners.
ICURE Pharmaceutical continuously invests in the most significant healthcare needs, and contributes to improve quality of life based on an Innovative Cure Technology.
CEO YoungKweon Choi, Ph.D.
|1984||B.S. College of Pharmacy, Seoul National University|
|1986||M.S. Dept. of Pharmaceutics, College of Pharmacy,|
Seoul National University
|1996||Ph.D. Dept. of Pharmaceutics, University of Utah, USA|
|1995||TGS visiting researcher|
|1996~1997||University of Utah CCCD Researcher|
|1997~2000||Senior Researcher at the Samyang Institute of Medicine|
|2000년||Icure Co., Ltd Ceo|
ICURE PHARM corporate responsibility believes that
all individuals, and everywhere deserve access to quality
healthcare and the opportunity to lead healthy lives.
ICURE PHARM pursues quality excellences including
human’s inner and external beauty through an Innovative
Be a MVP (Most Valuable Person) with M.V.P
(Mission, Vision, Passion)
that contributes to humanity
respecting for life.
이메일 무단수집을 거부합니다.
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 수집되는 것을 거부하며, 이를 위반시 정보통신망법에 의해 형사 처벌됨을 유념하시기 바랍니다.